Goserelin acetate 25 mg | 100.00%
TargetMol
Goserelin acetate is a synthetic long-acting agonist of gonadotropin-releasing hormone, used in treatments of cancer.
More Information Supplier PageGoserelin acetate
Search Results
Amcasertib 25 mg | Purity Not Available
TargetMol
Amcasertib is an orally administered investigational agent designed to inhibit cancer stem cell pathways via targeting stemness kinases.
More Information Supplier PageAmcasertib
Amcasertib 1 mg | Purity Not Available
TargetMol
Amcasertib is an orally administered investigational agent designed to inhibit cancer stem cell pathways via targeting stemness kinases.
More Information Supplier PageAmcasertib
AA26-9 10 mg | 100.00%
TargetMol
AA26-9 is an effective and broad-spectrum inhibitor of serine hydrolase.
More Information Supplier PageAA26-9
AA26-9 2 mg | 100.00%
TargetMol
AA26-9 is an effective and broad-spectrum inhibitor of serine hydrolase.
More Information Supplier PageAA26-9
AA26-9 1 mg | 100.00%
TargetMol
AA26-9 is an effective and broad-spectrum inhibitor of serine hydrolase.
More Information Supplier PageAA26-9
GDC-0326 2 mg | 99.79%
TargetMol
GDC-0326 is a potent and selective inhibitor of α-Isoform of Phosphoinositide 3-Kinase (PI3Kalpha inhibitor).
More Information Supplier PageGDC-0326
Su1498 2 mg | 99.54%
TargetMol
Su1498 (Tyrphostin SU 1498) is a selective inhibitor of the receptor tyrosine kinase VEGF receptor 2 (VEGFR2, aka FLK1; IC50 = 700 nM), having negligible activity at several other serine/threonine and tyrosine kinases.1, 2 It effectively blocks signaling through VEGFR2 both in vitro and in vivo.1, 3 SU 1498 is used to study the role […]
More Information Supplier PageSu1498
WEHI-345 2 mg | Purity Not Available
TargetMol
WEHI-345 is a potent and selective RIPK2 inhibitor which shows NOD signalling events yet prevents inflammatory cytokine production.
More Information Supplier PageWEHI-345
HG-14-10-04 2 mg | Purity Not Available
TargetMol
HG-14-10-04
